Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | GFER | P55789 | 1/20 | 0.30 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25673105 | 0.99 | KDM4E (0.45) | KDM4EATML3MBTL1MAPK8PTGER4 | |
| SCHEMBL25673106 | 0.99 | KDM4E (0.45) | KDM4EATML3MBTL1MAPK8PTGER4 | |
| SCHEMBL17463223 | 0.95 | KDM4E (0.46) | KDM4EATML3MBTL1MAPK8PTGER4 | |
| SCHEMBL12721957 | 0.95 | KDM4E (0.46) | KDM4EATML3MBTL1MAPK8PTGER4 | |
| SCHEMBL12231571 | 0.95 | KDM4E (0.49) | KDM4EATML3MBTL1MAPK8PTGER4 | |
| SCHEMBL22907670 | 0.93 | KDM4E (0.46) | KDM4EATML3MBTL1MAPK8MAPT | |
| SCHEMBL12231667 | 0.93 | L3MBTL1 (0.42) | KDM4EATML3MBTL1PTGER4MAPT | |
| SCHEMBL25672915 | 0.92 | KDM4E (0.46) | KDM4EATML3MBTL1MAPK8HSD17B10 | |
| SCHEMBL17463221 | 0.92 | KDM4E (0.49) | KDM4EATML3MBTL1MAPK8PTGER4 | |
| SCHEMBL15764072 | 0.92 | L3MBTL1 (0.41) | KDM4EATML3MBTL1PTGER4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142412-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-11 | — | — | US | disclosed |
| US-20230142412-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142412-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SLC1A2, CRY1, TEAD1 | KDM4E 620/4885ATM 2129/4885L3MBTL1 326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.